Full Name: Promab Biotechnologies
Headquarters: Fremont, California, USA
Founded: 2005
Focus: Monoclonal antibody development, contract manufacturing, immunotherapy
Type: Private biotechnology company
Website: promab.com
Promab Biotechnologies is a biotechnology company specializing in monoclonal antibody discovery, development, and manufacturing. The company provides contract research services and has developed proprietary antibody platforms for cancer and autoimmune diseases.
Founded in 2005 and headquartered in Fremont, California, Promab has established itself as a reliable partner for antibody-based research and therapeutic development. The company's location in California's Bay Area provides access to one of the world's largest biotechnology clusters, with proximity to leading pharmaceutical companies, research institutions, and experienced talent.
Promab was founded to address the growing demand for custom antibody development services. Over the years, the company has expanded from a service-focused model to include proprietary therapeutic programs.
The company's mission centers on accelerating antibody-based research and development through:
- High-quality antibody products
- Custom development services
- Manufacturing scale-up capabilities
- Collaborative research partnerships
Fremont, California, offers Promab strategic advantages including access to:
- World-class research institutions (Stanford, UCSF, UC Berkeley)
- Pharmaceutical company headquarters
- Experienced biotech workforce
- Venture capital and investment community
| Year |
Event |
| 2005 |
Company founded in Fremont, CA |
| 2008 |
Expanded to include antibody engineering services |
| 2012 |
Launched GMP manufacturing capabilities |
| 2016 |
Expanded neuroscience focus |
| 2020 |
Added bispecific antibody platform |
| 2023 |
Opened new manufacturing facility |
¶ Antibody Discovery
Promab employs multiple antibody discovery technologies:
Hybridoma Technology:
- Traditional mouse-based antibody generation
- Established methodology for high-affinity antibody discovery
- Rapid generation of monoclonal antibodies
Phage Display:
- Human antibody library screening
- Fully human antibody identification
- Directed evolution for improved properties
Single B Cell Cloning:
- Direct B cell isolation from immunized animals or humans
- Native antibody pairing
- Rapid antibody discovery from natural repertoires
¶ Antibody Engineering
Promab offers comprehensive antibody engineering capabilities:
- Antibody Humanization: Murine to human framework conversion for reduced immunogenicity
- Affinity Maturation: Engineering for improved binding affinity and specificity
- ADCC Enhancement: Fc region engineering for enhanced effector function
- Bispecific Antibodies: Multiple format options for dual-targeting
- Antibody-Drug Conjugates: Linker and payload optimization
- Cell Line Development: CHO and HEK293-based expression systems
- Process Development: Scalable purification and manufacturing processes
- GMP Manufacturing: Scale-up for clinical supply
- Analytical Services: Comprehensive characterization and quality control
Promab has significant experience in oncology antibody development:
- Cancer target identification and validation
- Antibody-drug conjugate (ADC) development
- Checkpoint inhibitor development
- CAR-T cell therapy support
¶ Neurology and Neurodegeneration
While primarily focused on oncology, Promab has capabilities directly relevant to neurodegenerative diseases:
- Anti-amyloid antibodies: Development platforms for Alzheimer's disease
- Tau-targeting antibodies: Research collaborations for tauopathies
- Neuroinflammation antibodies: IL-6, TNF-alpha targeting
- Neurodegeneration biomarkers: Antibody development for diagnostic assays
- Alpha-synuclein antibodies: Parkinson's disease research tools
- Prion protein antibodies: Prion disease applications
- Inflammatory cytokine targeting (IL-6, IL-1 beta, TNF-alpha)
- Receptor-blocking antibodies
- Immunomodulatory approaches
- Vaccine antigen development
- Diagnostic antibody development
- Therapeutic antibody platforms
Promab provides comprehensive contract research services:
- Custom Antibody Development: From antigen design to purified antibody
- Immunogen Design: Peptide and protein antigen development
- Assay Development: ELISA, IHC, and flow cytometry platforms
- Contract Research: Custom research projects for biotechnology and pharma
- Cell Line Development: Stable cell line generation
- GMP Manufacturing: Scale-up for clinical supply
- Protein Expression: Recombinant protein production
Promab maintains rigorous quality standards:
- ISO 9001 certified operations
- GMP-compliant manufacturing
- Rigorous QC/QA protocols
- Standardized validation procedures
- Analytical method validation
- Stability testing programs
Promab supports research across multiple domains:
- Neuroscience biomarkers
- Cancer immunotherapy targets
- Infectious disease antigens
- Autoimmune disease markers
- Cardiovascular disease markers
- Metabolic disease research
Promab maintains diverse partnerships:
- Academic research partnerships with leading universities
- Pharmaceutical company contracts
- Biotechnology collaborations
- Government research grants
- Foundation-funded research
Promab's capabilities are directly relevant to neurodegenerative disease research:
- Amyloid-beta antibody development platforms
- Tau protein antibody generation
- Biomarker assay development
- Research reagent supply for academic labs
- Alpha-synuclein antibody development
- LRRK2 antibody tools
- Diagnostic assay development
- Lysosomal function research
- ALS antibody research tools
- Prion disease applications
- Multiple sclerosis research tools
- Huntington's disease research
Promab can support neurodegenerative research through:
- Custom antibody generation for specific targets
- Assay development for biomarkers
- Cell line development for disease models
- GMP production for clinical studies
¶ Competitive Landscape
Promab operates in the competitive antibody services market:
| Company |
Focus |
Strength |
| Promab |
Custom services |
Flexibility, speed, custom solutions |
| Abcam |
Research antibodies |
Catalog breadth |
| Thermo Fisher |
Commercial antibodies |
Scale, distribution |
| BioLegend |
Flow cytometry |
Specialty, reproducibility |
| Covance |
Contract research |
Full-service CRO |
Promab differentiates through:
- Custom project flexibility
- Rapid turnaround times
- Scientific expertise
- Collaborative approach